Philip Turnbull GlaxoSmithKline

Event Date:
March 18, 2013 – 4:00 PM to March 19, 2013 – 4:59 PM

Location:
Burson 115

Event Date:
March 18, 2013 – 4:00 PM to March 19, 2013 – 4:59 PM

Location:
Burson 115

SEMINAR SERIES
SPRING 2013

Philip Turnbull

GlaxoSmithKline

Will be presenting

“SARMs and Beyond: Emerging Pharmacotherapies Targeting Skeletal Muscle Disorders”

Abstract:

Skeletal muscle is emerging as a key target tissue for drug discovery. Vast opportunities exist for therapeutic interventions targeting muscle wasting, metabolic disorders, contractility, and motor neuron disorders. Selective androgen receptor modulators (SARMs) have arisen as one of the first viable therapies for muscle wasting disorders. Other therapies on the horizon are focused on leveraging negative regulators of muscle mass in the TGF beta signaling pathway. This seminar will focus the development of SARMs at GSK and how SARMs fit into the context of other pharmacotherapies being developed for skeletal muscle disorders.

Monday, March 18, 2013 @ 4:00pm Rm. 115 Burson

Refreshments served @ 3:45